Jefferies raises Spyre Therapeutics target price to $129 from $126
SYRE•Jefferies raised its target price for Spyre Therapeutics to $129 from $126.
Related News
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal
SNY•
Regeneron, Sanofi expand antibody alliance with $1 billion upfront payment
REGN•
Old National Bancorp: JPMorgan cuts target price to $30 from $32
ONB•
Tencent reportedly leases 100,000 chips from Oracle to accelerate AI push
ORCL•
Fresenius buys remaining 45% of mAbxience for up to EUR 750 million
FSNUY•